Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jacobio Pharmaceuticals Group Co., Ltd. ( (HK:1167) ) has issued an update.
Jacobio Pharmaceuticals Group Co., Ltd. announced that its parties acting in concert have increased their shareholdings by purchasing an additional 60,900 shares on the open market. This move reflects strong confidence in the company’s growth prospects and long-term investment value, with the Concert Parties now holding approximately 25.36% of the total issued shares. The shareholding increase was conducted in compliance with applicable laws and regulations, and there is potential for further increases in the future.
The most recent analyst rating on (HK:1167) stock is a Hold with a HK$3.70 price target. To see the full list of analyst forecasts on Jacobio Pharmaceuticals Group Co., Ltd. stock, see the HK:1167 Stock Forecast page.
More about Jacobio Pharmaceuticals Group Co., Ltd.
Jacobio Pharmaceuticals Group Co., Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. The company focuses on the development and commercialization of innovative drugs, with a market focus on long-term growth and investment potential.
Average Trading Volume: 7,009,437
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.93B
Find detailed analytics on 1167 stock on TipRanks’ Stock Analysis page.